Monitoring and maintenance of arteriovenous fistulae and graft function in haemodialysis patients

Current Opinion in Nephrology and Hypertension

Volumn 13, Issue 6, 2004, Pages 655-660

  Tonelli, Marcello ^a,b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INSTITUTE OF HEALTH ECONOMICS   (Canada)

^c 7 129 Clinical Sciences Building ^*  (Canada)

Author keywords

Arteriovenous shunt; Haemodialysis; Surgical; Vascular access

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO; POLITEF;

ANGIOGRAPHY; ANGIOPLASTY; ARTERIOVENOUS FISTULA; BEAM THERAPY; BLEEDING; BLOOD FLOWMETRY; BLOOD VESSEL GRAFT; BLOOD VESSEL OCCLUSION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; FOLLOW UP; GRAFT PATENCY; HEALTH CARE COST; HEMODIALYSIS; HEMODYNAMIC MONITORING; HUMAN; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; VALIDATION PROCESS; VASCULAR ACCESS; VENOUS PRESSURE;

ARTERIOVENOUS SHUNT, SURGICAL; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; GRAFT OCCLUSION, VASCULAR; HUMANS; POLYTETRAFLUOROETHYLENE; RENAL DIALYSIS;

EID: 8644236459     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200411000-00012     Document Type: Review

References (32)

1. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004; 15:477-486.
2. Oliver MJ, Rothwell DM, Fung K, et al. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 2004; 15:1936-1942.
3. Tonelli M, Jindal K, Hirsch D, et al. Screening for subclinical stenosis in native vessel arteriovenous fistulae. J Am Soc Nephrol 2001; 12:1729-1733.
4. Jindal KK, Ethier J, Lindsay RM, et al. Clinical practice guidelines for vascular access. Canadian Society of Nephrology. J Am Soc Nephrol 1999; 10 (Suppl. 13):S287-S321.
5. Bouchouareb D, Saveanu A, Bartoli JM, Olmer M. A new approach to evaluate vascular access in hemodialysis patients. Artif Organs 1998; 22:591-595.
6. Lindsay RM, Blake PG, Malek P, et al. Hemodialysis access blood flow rates can be measured by a differential conductivity technique and are predictive of access clotting. Am J Kidney Dis 1997; 30:475-482.
7. Tonelli M, Hirsch D, Clark TW, et al. Access flow monitoring of patients with native vessel arteriovenous fistulae and previous angioplasty. J Am Soc Nephrol 2002; 13:2969-2973.
8. Schwab SJ, Oliver MJ, Suhocki P, McCann R. Hemodialysis arteriovenous access: detection of stenosis and response to treatment by vascular access blood flow. Kidney Int 2001; 59:358-362.
9. Moist LM, Churchill DN, House AA, et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol 2003; 14:2645-2653. A carefully conducted randomized trial that showed no benefit associated with access monitoring using Qa measurements in grafts (compared with VPM).
10. Paulson WD, Ram SJ, Birk CG, Work J. Does blood flow accurately predict thrombosis or failure of hemodialysis synthetic grafts? A meta-analysis. Am J Kidney Dis 1999; 34:478-485.
11. Hakim R, Himmelfarb J. Hemodialysis access failure: a call to action. Kidney Int 1998; 54:1029-1040.
12. Garland JS, Moist LM, Lindsay RM. Are hemodialysis access flow measurements by ultrasound dilution the standard of care for access surveillance? Adv Renal Replace Ther 2002; 9:91-98.
13. Lopot F, Nejedly B, Sulkova S, Blaha J. Comparison of different techniques of hemodialysis vascular access flow evaluation, Int J Artif Organs 2003; 26: 1056-1063.
14. Schwarz C, Mitterbauer C, Boczula M, et al. Flow monitoring: performance characteristics of ultrasound dilution versus color Doppler ultrasound compared with fistulography. Am J Kidney Dis 2003; 42:539-545.
15. Ram SJ, Magnasco A, Jones SA, et al. In vivo validation of glucose pump test for measurement of hemodialysis access flow. Am J Kidney Dis 2003; 42:752-760.
16. Magnasco A, Bacchini G, Cappello A, et al. Clinical validation of glucose pump test (GPT) compared with ultrasound dilution technology in arteriovenous graft surveillance. Nephrol Dial Transplant 2004; 19:1835-1841.
17. Tessitore N, Bedogna V, Gammaro L, et al. Diagnostic accuracy of ultrasound dilution access blood flow measurement in detecting stenosis and predicting thrombosis in native forearm arteriovenous fistulae for hemodialysis. Am J Kidney Dis 2003; 42:331-341. This study demonstrates the relationship between Qa and stenosis in a consecutive series of fistulae, all of which underwent angiography (regardless of the clinical context).
18. Tonelli M, Jhangri GS, Hirsch DJ, et al. Best threshold for diagnosis of stenosis or thrombosis within six months of access flow measurement in arteriovenous fistulae. J Am Soc Nephrol 2003; 14:3264-3269.
19. Ram SJ, Work J, Caldito GC, et al. A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney Int 2003; 64:272-280. A good quality randomized trial that showed no benefit associated with access monitoring (Qa measurements or ultrasound), compared with no monitoring.
20. Tessitore N, Mansueto G, Bedogna V, et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. J Am Soc Nephrol 2003; 14:1623-1627. A controlled study showing that angioplasty of stenosis in fistulae is associated with improved patency and reduced vascular access morbidity.
21. King SB III, Williams DO, Chougule P, et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation 1998; 97:2025-2030.
22. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358:527-533.
23. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM. Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Kidney Int 1994; 45:1477-1483.
24. Saran R, Dykstra DM, Wolfe RA, et al. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2002; 40:1255-1263.
25. Kobayashi K, Maeda K, Koshikawa S, et al. Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis - a multicenter collaborative double blind study. Thromb Res 1980; 20:255-261.
26. van Tongeren RB, Levendag PC, Coen VL, et al. External beam radiation therapy to prevent anastomotic intimal hyperplasia in prosthetic arteriovenous fistulas: results of a randomized trial. Radiother Oncol 2003; 69:73-77.
27. Kaufman JS, O'Connor TZ, Zhang JH, et al. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol 2003; 14:2313-2321. A randomized study showing that combination therapy with clopidogrel and aspirin significantly increase the risk of bleeding in haemodialysis patients, and are unlikely to prevent graft thrombosis.
28. Alton M, Lockhart ME, Lilly RZ, et al. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int 2001; 60:2013-2020.
29. Malovrh M. Native arteriovenous fistula: preoperative evaluation. Am J Kidney Dis 2002; 39:1218-1225.
30. Beathard GA, Settle SM, Shields MW. Salvage of the nonfunctioning arteriovenous fistula. Am J Kidney Dis 1999; 33:910-916.
31. O'Hare AM, Dudley RA, Hynes DM, et al. Impact of surgeon and surgical center characteristics on choice of permanent vascular access. Kidney Int 2003; 64:681-689.
32. Oliver MJ, McCann RL, Indridason OS, et al. Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. Kidney Int 2001; 60:1532-1539.